Wells Fargo’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.81K Sell
921
-2,219
-71% -$16.4K ﹤0.01% 5569
2025
Q1
$27K Buy
3,140
+441
+16% +$3.79K ﹤0.01% 5152
2024
Q4
$96.5K Buy
2,699
+774
+40% +$27.7K ﹤0.01% 4734
2024
Q3
$90.9K Buy
1,925
+34
+2% +$1.61K ﹤0.01% 4678
2024
Q2
$95K Buy
1,891
+386
+26% +$19.4K ﹤0.01% 4609
2024
Q1
$169K Buy
1,505
+272
+22% +$30.5K ﹤0.01% 4207
2023
Q4
$71.5K Buy
1,233
+312
+34% +$18.1K ﹤0.01% 4692
2023
Q3
$29.2K Sell
921
-3,195
-78% -$101K ﹤0.01% 5081
2023
Q2
$339K Buy
4,116
+225
+6% +$18.5K ﹤0.01% 4012
2023
Q1
$400K Buy
+3,891
New +$400K ﹤0.01% 3753
2022
Q4
Sell
-62
Closed -$10K 7269
2022
Q3
$10K Buy
62
+16
+35% +$2.58K ﹤0.01% 5356
2022
Q2
$5K Sell
46
-663
-94% -$72.1K ﹤0.01% 5711
2022
Q1
$71K Sell
709
-961
-58% -$96.2K ﹤0.01% 5157
2021
Q4
$259K Buy
1,670
+1,456
+680% +$226K ﹤0.01% 4767
2021
Q3
$50K Buy
214
+212
+10,600% +$49.5K ﹤0.01% 5322
2021
Q2
$1K Sell
2
-852
-100% -$426K ﹤0.01% 6353
2021
Q1
$345K Sell
854
-4,068
-83% -$1.64M ﹤0.01% 4580
2020
Q4
$3.28M Sell
4,922
-245
-5% -$163K ﹤0.01% 3079
2020
Q3
$2.41M Buy
5,167
+435
+9% +$202K ﹤0.01% 3122
2020
Q2
$2.77M Buy
4,732
+1,675
+55% +$980K ﹤0.01% 2967
2020
Q1
$446K Buy
3,057
+1,401
+85% +$204K ﹤0.01% 3997
2019
Q4
$237K Sell
1,656
-337
-17% -$48.2K ﹤0.01% 4700
2019
Q3
$78K Buy
1,993
+1,802
+943% +$70.5K ﹤0.01% 5167
2019
Q2
$19K Sell
191
-38
-17% -$3.78K ﹤0.01% 5443
2019
Q1
$30K Sell
229
-1
-0.4% -$131 ﹤0.01% 5331
2018
Q4
$23K Sell
230
-437
-66% -$43.7K ﹤0.01% 5406
2018
Q3
$166K Buy
667
+4
+0.6% +$996 ﹤0.01% 4906
2018
Q2
$297K Buy
663
+439
+196% +$197K ﹤0.01% 4665
2018
Q1
$88K Buy
224
+38
+20% +$14.9K ﹤0.01% 5111
2017
Q4
$76K Buy
186
+172
+1,229% +$70.3K ﹤0.01% 5163
2017
Q3
$6K Buy
+14
New +$6K ﹤0.01% 5606